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Lipopolysaccharide inhalation recruits monocytes
and dendritic cell subsets to the alveolar airspace
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Mononuclear phagocytes (MPs) including monocytes, macrophages and dendritic cells
(DCs) are critical innate immune effectors and initiators of the adaptive immune response.
MPs are present in the alveolar airspace at steady state, however little is known about DC
recruitment in acute pulmonary inflammation. Here we use lipopolysaccharide inhalation to
induce acute inflammation in healthy volunteers and examine the impact on bronchoalveolar
lavage fluid and blood MP repertoire. Classical monocytes and two DC subsets (DC2/3 and
DC5) are expanded in bronchoalveolar lavage fluid 8 h after lipopolysaccharide inhalation.
Surface phenotyping, gene expression profiling and parallel analysis of blood indicate
recruited DCs are blood-derived. Recruited monocytes and DCs rapidly adopt typical
airspace-resident MP gene expression profiles. Following lipopolysaccharide inhalation,
alveolar macrophages strongly up-regulate cytokines for MP recruitment. Our study defines
the characteristics of human DCs and monocytes recruited into bronchoalveolar space
immediately following localised acute inflammatory stimulus in vivo.
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The alveoli of the lung present a large but fragile surfacearea to the environment. Maintaining the integrity ofthe alveolar-capillary membrane is critical to effective gas
exchange. Immune regulation at this interface must control
infection and limit immunopathology. Mononuclear phagocytes
(MPs), comprising monocytes, macrophages, and dendritic cells
(DCs) have a critical role at any environmental interface as innate
immune effectors equipped to shape the adaptive immune
response through antigen presentation, co-stimulation, and
cytokine production.
Leukocytes from the alveolar airspace can be readily isolated by
bronchoscopy and bronchoalveolar lavage (BAL). BAL has been
less extensively characterized than lung tissue but presents a
number of advantages as a window to the lung’s immune system:
BAL yields a cell suspension free from contaminating blood
leukocytes with minimal processing requirement thus preserving
surface antigens and native activation status.
MPs in any anatomical compartment are a heterogeneous
group of leukocytes. Establishing the steady-state repertoire of a
compartment is crucial to understanding infiltrates seen in
inflammation. Most tissues contain embryonically-derived mac-
rophages with variable contributions from circulating monocytes
depending on how available the tissue niche is1,2. Monocyte-
derived cells are observed adopting a spectrum of macrophage
or DC features depending on the tissue. While steady state
monocyte-derived DCs are observed in mouse skin and gut3–5,
their existence in human tissues has not been convincingly
established. DCs are broadly divided into plasmacytoid DCs
(pDC) that characteristically produce IFN-α and conventional
DCs (cDC) that effectively stimulate T cell proliferation6. Two
subsets of cDCs with homology across species have been clearly
identified. cDC1 expresses CD141, CLEC9A, and XCR1 in
humans and is adept at cross-presenting antigen7–11. cDC2
expresses CD1c in humans and is important for activation of CD4
T cells, induction of regulatory T cells and activation of Th2 and
Th17 responses12,13.
A number of recent studies have capitalized on multi-
parameter flow cytometry to define subsets of MPs across
human lung compartments14–18, but differences in approach have
led to continued debate about whether rare DC subsets (pDC and
cDC1) exist in BAL or have been inadvertently excluded during
analysis. As blood is a source of tissue-recruited leukocytes, a
logical approach would use blood MP definitions to classify tissue
MPs. Recent insights from single cell RNA sequencing have
revealed additional complexity in our understanding of blood
MPs, including the presence of previously undiscovered DC
subsets, and heterogeneity within existing subsets19. Briefly, this
confirmed the presence of cDC1 (DC1) and pDC (pDC or DC6).
It revealed two subdivisions within cDC2 (DC2, DC3) and
identified additional DCs subsets: Axl+Siglec−6+ DCs (AS DC
or DC5) and CD1c-CD141− DCs (DC4). To date, this revised
classification has not been tested in non-lymphoid tissue.
As our understanding of the BAL MP repertoire in steady state
develops, it becomes tangible to address the question of what
happens during inflammation. In mice, inflammatory macrophages
and DCs have been described in numerous infection and sterile
inflammation models20–25. Monocytes are thought to be the source
of inflammatory DCs, based on studies in CCR2 and Flt3-deficient
animals and adoptive transfer of monocytes20–24. Distinct inflam-
matory macrophages and DCs have also been identified in human
chronic inflammatory exudates26. These inflammatory DCs are
proposed to arise from monocytes based on transcriptional simi-
larity to in vitro monocyte-derived DCs26. Early time-points of
inflammation have not been adequately explored.
Here, we use inhaled lipopolysaccharide (LPS) as an experi-
mental inflammatory stimulus to reproducibly study the earliest
events in human lung inflammation. Eight MP subsets can be
identified in steady state BAL following sterile saline inhalation
(SS-BAL), in line with subsets described in blood. Monocytes and
two myeloid DC subsets (DC2/3 and DC5) are recruited as early
as 8 h following LPS inhalation (LPS-BAL) and rapidly adopt
gene expression profiles characteristic of airspace MP residence.
The cytokine and chemokine profile of BAL implicates AMs as
the likely instigator of blood monocyte and DC recruitment into
the alveolar airspace during acute inflammation.
Results
Accumulation of alveolar neutrophils, monocytes, and DCs.
The steady state MP repertoire of BAL was defined by flow
cytometry in healthy individuals 8 h after inhalation of isotonic
saline (Fig. 1a, Supplementary Fig. 1). We used a recent
description of human blood MP diversity based on single cell
RNA-sequencing as a template for identifying BAL MP popula-
tions19. As an adaption for BAL analysis, we first used side scatter
and CD45 expression to exclude CD45loSSCmid neutrophils and
identify alveolar macrophages (AM) as CD45+SSChi cells (Sup-
plementary Fig. 1). BAL CD45+SSClo cells were then comparable
to peripheral blood mononuclear cells (PBMC) (Fig. 1b). Per-
ipheral blood was sourced from healthy controls (HC) that had
not received inhalation challenge. CD45+SSClo cells that
expressed HLA-DR but not lineage markers (CD3, 19, 20, 56)
were gated into CD14++CD16−, CD14++CD16+, and CD14+
CD16++ fractions analogous to blood classical, intermediate and
non-classical monocytes, respectively. The CD14−CD16− frac-
tion containing DCs was first probed for the rare Axl+Siglec6+
population (DC5) as its varied expression of CD123 and CD11c
would otherwise place it within pDC and cDC gates. After DC5
exclusion, CD123+CD11clo cells identified pDC and further
segregation of the CD11c+ cells using a combination of BTLA
and CD1c identified DC1 and DC2/3. While DC1 is most typi-
cally defined by its expression of CD141 or CLEC9A, immune
gene expression by cells sorted from the BTLAhi gate expressed
the expected gene profile of DC1, confirming the validity of this
approach (Supplementary Fig. 1). We did detect a population
of CD11c+CD1c−BTLA− cells within our DC gate, which are
likely to correspond to DC4 described in Villani et al., but can
only refer to these as CD11c+CD1c− cells without further
characterization.
The dominant MP subset in SS-BAL was the AM (Table 1).
Comparing SS-BAL CD45+SSClo cells with PBMC, MPs were
richer in SS-BAL (Table 1). Of MPs, the most abundant subset
was a CD14++CD16+ population (Table 1; Fig. 1d). CD14++
CD16− cells, analogous to classical monocytes in blood, were
comparatively rare in SS-BAL and CD14+CD16++ cells,
analogous to non-classical blood monocytes, were virtually
absent. All DC subsets, especially CD1c-expressing DC1 and
DC2, were enriched in SS-BAL relative to blood.
Following LPS inhalation, the greatest leukocyte expansion was
in CD14++CD16− MPs (400-fold difference in mean concentra-
tion between SS-BAL and LPS-BAL), followed by neutrophils
and DCs (Fig. 1c). Amongst DCs, the concentrations of CD1c+
DCs (DC2/3) and DC5 were selectively increased (Fig. 1c).
To examine the impact of acute lung inflammation on
peripheral blood MP populations, their concentrations were
tracked at 2-h intervals following inhalation of LPS or saline
(Fig. 1e). Neutrophils, which were abundant in LPS-BAL and
pDCs, which were not enriched in LPS-BAL, were tracked for
comparison with monocytes and DCs. Following saline inhala-
tion, no differences in leukocyte concentrations occurred
compared with baseline. Following LPS inhalation, blood
neutrophil concentration rose progressively, but pDC and
ARTICLE NATURE COMMUNICATIONS | https://doi.org/10.1038/s41467-019-09913-4
2 NATURE COMMUNICATIONS |         (2019) 10:1999  | https://doi.org/10.1038/s41467-019-09913-4 | www.nature.com/naturecommunications
monocyte concentrations remained static. Blood DC2/3 concen-
tration fell significantly within 2 h of LPS inhalation.
Alveolar CD14++CD16− MPs are recruited blood monocytes.
As CD14++CD16− MPs were particularly enriched in LPS-BAL,
we focused on this population to interrogate the molecular
changes of tissue adaptation in vivo following acute inflammatory
challenge. The surface antigen phenotype of LPS-BAL CD14++
CD16− MPs by flow cytometry resembled that of blood mono-
cytes. LPS-BAL CD14++CD16− cells expressed genes char-
acteristic of classical monocytes including CD14, CCR2 and SELL
but did not express FCGR3A/B (CD16), CD79b, and CX3CR1,
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which are characteristic of non-classical monocytes27 (Fig. 2a).
However, unsupervised transcriptome analysis revealed distinct
changes as a consequence of recruitment into the alveolar
airspace.
Using the NanoString Immunology V2 579-gene panel, we
compared the expression profile of HC blood monocyte subsets
with SS-BAL and LPS-BAL monocyte-macrophages. By principal
component analysis, the first principal component (PC1)
segregated cells by tissue compartment (blood versus BAL) and
the second (PC2) separated monocyte-macrophages from resi-
dent alveolar macrophages (Fig. 2b). PC3 separated the CD14+
+CD16− cells from SS-BAL and LPS-BAL. The distance between
BAL CD14++CD16− MPs and monocytes, even by principal
components 2 and 3, suggested adoption of a unique gene
expression profile upon entry to the airspace. This was explored
further by examination of differentially expressed genes (DEGs).
We performed pairwise comparisons of DEGs of CD14++
CD16− cells between tissue compartments (HC blood vs. BAL)
and between inflammatory states (SS-BAL vs. LPS-BAL). There
was a core signature of 49 DEGs (11% of the 457 genes expressed
in these cell types) distinguishing SS-BAL and LPS-BAL CD14++
CD16− MPs from HC blood classical monocytes (Fig. 2c,
Supplementary Dataset 1). The 36 up-regulated included genes
encoding phagocytic receptors (MRC1, FCGR3A/B, MSR1),
immunoregulatory proteins (CD274), innate immune effectors
(C1QA/B), chemokines capable of monocyte and lymphocyte
recruitment (CXCL10), and some genes associated with mature
DC function (CD80, LAMP3). This supported the interpretation
that CD14++CD16− MPs are recruited blood monocytes with
maturation and adaptation to the alveolar environment.
Comparing CD14++CD16− MPs in SS-BAL and LPS-BAL, 98
genes (21%) were differentially expressed (Fig. 2d, Supplementary
Dataset 1). Steady state (SS-BAL) was associated with higher
expression genes involved in antigen presentation (CD1A, HLA-
DPA1, HLA-DMB, HLA-DOB, CD1D), pathogen clearance
(CD209, MRC1), control of inflammatory signaling (PTPN22),
and the ability to activate the allergic responses (FCEFR1A).
Inflammation (LPS-BAL) saw activation of LPS response genes
(IL1A, IL1B, IRAK2, TRAF3, and others) retention of monocyte-
associated genes (S100A8/9, SELL), and marked expression of
chemokine genes (CCL2/3/4/5/7, CXCL10, and IL8). This suggests
that in quiescence, CD14++CD16− MPs have the capacity to
present antigen, possibly helping to maintain tolerance, while in
inflammation, they are primed to modulate immune functions
through chemokine and interleukin production.
Blood CD1c+ DC are recruited into the alveolar space. We used
a panel of antigens showing divergent expression on tissue and
blood CD1c-expressing DCs (DC2/3) to evaluate the flow cyto-
metry phenotype of CD1c+ DCs found in SS-BAL, LPS-BAL and
HC blood14,26,28 (Fig. 3a). Blood DC2/3 were CD11blo, Axl−,
CD1a−, and CD206− while SS-BAL DC2/3 expressed all four of
these antigens, confirming that these were genuine tissue DCs and
not blood contaminants. However, the expression of these anti-
gens on LPS-BAL DC2/3 paralleled that seen in blood DC2/3.
Significant blood contamination of LPS-BAL was excluded by
Fig. 1 Neutrophils and mononuclear phagocytes are expanded in the alveolar airspace following LPS inhalation. a Schematic overview of study design. Solid
arrows denote LPS inhalation (red) or saline inhalation control (blue). Black arrows denote blood sampling. Dashed arrows denote BAL. b Flow cytometry
of leukocyte preparations from SS-BAL, LPS-BAL, and HC blood. The CD45 versus SSC plot was used to define CD45+SSChi AM, CD45loSSCmid
neutrophils and CD45+SSClo mononuclear cells (see also Supplementary Fig. 1). Monocyte/macrophages and DCs were negative for lineage markers CD3,
CD19, CD20, and CD56 and expressed HLA-DR. Monocyte/macrophages were divided into CD14++CD16−, CD14++CD16+, and CD14-CD16++
populations analogous to blood classical, intermediate and non-classical monocytes. DCs within the CD14-CD16− gate were divided into subsets: Axl+
Siglec6+ DC5s, CD11cloCD123+ pDCs, CD1c+BTLAlo-mid DC2/3s, and BTLAhi DC1s. Plots are representative of n= 9 SS BAL and n= 10 LPS BAL.
c Concentrations of neutrophil, monocyte/macrophage and DC subsets in SS-BAL and LPS BAL. Bars represent mean and lines SEM. p-values from
unpaired t-tests of SS versus LPS are shown: “ns” p > 0.05, *p < 0.05, **p < 0.01, ***p < 0.001, ****p < 0.0001. d Monocyte/macrophage and DC frequency
in HC blood, SS-BAL and LPS-BAL as a proportion of SSClo MHC class II-expressing cells (not-including CD1c- DCs). e Concentration of selected leukocyte
populations in peripheral blood at 2-h intervals following inhalation of saline (blue line) or LPS (red line). Data points show mean ± SEM for 3–5
participants. p-values from one-way ANOVA are shown. p-value representation is described in c
Table 1 Frequency of MP subsets in BAL and blood
MP subset AM CD14++
CD16−
CD14++
CD16+
CD14+
CD16++
DC1 DC2/3 CD1c− DC5 pDC
Antigen
expression
by flow
cytometry
CD45 + + + + + + + + +
SSC hi lo lo lo lo lo lo lo lo
Lineage − − − − − − − − −
HLA-DR + + + + + + + + +
CD14 + ++ ++ + − − − − −
CD16 + − + ++ − − − − −
CD11c + + + -/+ −
CD123 − − − −/+ +
BTLA ++ −/+ − + +
CD1c +/− + − -/+ −
Axl +/− +/− +/− + −
Siglec 6 − − − + −
% of l
eukocytes
mean (SD)
% of MPs
mean (SD)
HC whole blood 0 8.01 (2.04) 0.47 (0.22) 1.29 (0.85) 0.02 (0.01) 0.30 (0.1) 0.07 (0.07) 0.02 (0.02) 0.23 (0.05)
75.0 (7.94) 6.41 (2.29) 13.8 (6.11) 0.23 (0.22) 1.07 (0.75) 0.77 (0.72) 0.22 (0.20) 1.93 (0.93)
SS BAL 60.1 (14.3) 1.06 (0.14) 2.38 (0.95) 0.64 (0.56) 0.12 (0.10) 0.82 (0.35) 0.69 (0.72) 0.04 (0.02) 0.13 (0.07)
2.92 (1.88) 43.7 (8.00) 11.4 (7.31) 2.41 (1.91) 16.1 (4.24) 12.3 (13.9) 1.06 (0.36) 2.57 (1.53)
LPS BAL 23.1 (13.5) 18.7 (9.13) 4.51 (3.23) 0.23 (0.16) 0.09 (0.04) 1.63 (0.61) 0.2 (0.11) 0.14 (0.05) 0.22 (0.16)
64.3 (17.8) 18.2 (16.6) 0.91 (0.67) 0.33 (0.15) 6.12 (2.59) 0.69 (0.37) 0.45 (0.11) 0.76 (0.49)
MP subsets present in BAL. MP subsets are defined by the flow cytometry gates in Fig. 1b. Expression of defining antigens is indicated as “++” bright expression, “+” positive expression, “+/−” low-level
expression or “−” no expression. Where no symbol is given, expression was not measured on that subset. Frequencies of each MP subset in whole blood, SS BAL and LPS BAL are given. In standard type,
frequencies are given as a percentage of total leukocytes (defined as CD45+ cells). In italic type, frequencies are given as a percentage of MPs (defined as CD45+SSClo, CD3,19,20,56− HLA-DR+ cells)
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counting erythrocytes: 16.7 × 106 ± 28.4 × 106 in SS-BAL and
33.3 × 106 ± 30.8 × 106 in LPS-BAL (mean ± SD; p= 0.04 by
unpaired t-test). This amounted to a 6 μl blood leak, permitting
approximately 0.4% of the 105 DC2/3 found in LPS-BAL to be
due to blood contaminants (DC2/3 frequency in peripheral
blood is approximately 10 cells μl−129).
While the surface antigen phenotype of LPS-BAL DC2/3 by
flow cytometry supported their rapid recruitment from blood
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DC2/3, consideration was also given to the possibility that they
may have differentiated from recruited blood monocytes. The
latter possibility was considered less likely within the eight-hour
time window studied. Microarray analysis in human chronic
inflammatory exudates aligned inflammatory CD1c-expressing
DCs with in vitro monocyte-derived DCs26. From a list of
conserved genes defining human and mouse monocytes and
macrophages compared to DCs28, 25 genes were evaluable on the
Nanostring Immunology V2 panel. Hierarchical clustering the
expression of these genes located LPS-BAL DC2/3 closest to SS-
BAL DC2/3 and HC blood DC2/3 and remote from HC blood
monocytes, BAL macrophages and in vitro monocyte-derived
DCs (Fig. 3b). Furthermore, LPS-BAL CD1c-expressing MPs
were effective stimulators of allogeneic T cell proliferation, in
contrast to LPS-BAL CD14++CD16− MPs and AMs, further
supporting their origin from circulating CD1c-expressing blood
DCs (Fig. 3c).
We next explored the functional adaptations to airspace
residence of recruited blood DCs by comparing the immune
gene expression profile of blood DC2/3 with their SS-BAL and
LPS-BAL counterparts (Fig. 3d, Supplementary Dataset 1). There
was a core signature of 100 DEGs in SS and LPS BAL DC2/3
compared with HC blood DC2/3 (21% of the 466 genes expressed
in these cell types): 39 upregulated and 61 downregulated genes.
Up-regulated genes were required for mature DC function
(CD80, CCR7, LAMP3), involved in immunoregulation (CISH,
CD274, CD276, TNFRSF11A), monocyte and T cell recruitment
(CCL2, CCL22), and pathogen recognition or scavenging
(CLEC5A, MSR1). The genes most down-regulated in BAL
DC2/3 compared with blood DC2/3 included CD1D, possibly as
an adaptation to the lipoprotein-rich alveolar environment, and
the lymphoid-lineage associated genes CD22 and CD244.
Relatively few genes were differentially expressed between SS
and LPS BAL DC2/3 (Fig. 3e, Supplementary Dataset 1). As with
LPS CD14++CD16−MPs, LPS DC2/3 expressed LPS response
genes (IL1B, IL8, IRAK2) and chemokine genes (CCL2,4,5
CXCL10,11) to a greater extent than SS-BAL DC2/3.
CD1c+ DC heterogeneity within the alveolar space. The flow
cytometry gating strategy used for parallel examination of BAL
and blood revealed heterogeneity in the CD1c-expressing DC gate
by BTLA expression (Fig. 1b). In blood, BTLA expression seg-
regates CD1c-expressing DCs into two subsets with distinct gene
expression profiles, with BTLA+ DC expressing lymphocyte
lineage genes including CD5, CD79A/B and CD24 and BTLA−
DC expressing monocyte/macrophage genes such as CD14,
S100A8/9 and F13A1 (Fig. 4a). Gene expression differences
between blood BTLA+ and BTLA− DC correlate with gene
expression differences between blood DC2 (HLA−class II genes)
and DC3 (BST1, CD14, CD163, S100A8/9)19 (Fig. 4a) and with
blood CD1c+ DC subsets segregated by CD5 expression30.
In BAL, BTLA expression discerned two subsets with the mean
fluorescence intensity for BTLA+ cells at 1 × 103 (corresponding
to DC2) and BTLA− cells at 100 (corresponding to DC3)
(Fig. 4b). The ratio of DC2:DC3 in HC blood was 40:60. In
contrast, SS-BAL showed marked skewing towards DC3 (20:80).
In keeping with our previous findings suggesting that LPS-BAL
CD1c+ DCs are recruited from circulating DCs, the DC2:DC3
ratio in LPS-BAL approximated that of blood.
The genes differentially expressed between HC blood DC2 and
DC3 were not recapitulated between LPS-BAL DC2 and DC3
(Fig. 4c). The convergence in gene expression between LPS-BAL
CD1c+ DC subsets following recruitment to BAL may be
accounted for by inflammation (SLAMF7, TNFRSF9), as well as
change of compartment (CXCL9, FCGR3A/B, S100A8/9).
Both blood CD1c+ subsets effectively stimulate allogeneic T
cell production19,30 but have distinct capacity for inducing
cytokine production by CD4+ T cells, with CD5+CD1c+ DCs
(representing DC2 or BTLA+ DC) inducing IL-10, IL-22, IL-4,
and IL-17 production) and CD5loCD1c+ DCs (representing DC3
or BTLA- DC) inducing IFN-γ production. We therefore
compared the capacity of LPS-BAL DC2 and DC3 to influence
cytokine production by CD4+ T cells. We observed that both
subsets were equally capable of inducing IFN-γ and IL-17
production without any IL-4 production. The capacity to induce
IFN-γ production was significantly greater in LPS-BAL than SS-
BAL DC2/3. Yet, even SS-BAL DC2 did not induce IL-4
production, supporting the concept that CD1c+DCs undergo
functional alteration upon tissue entry (Fig. 4d).
The Axl+Siglec-6+ DC5 population, while enriched in LPS-
BAL, remained too small to analyse in functional assays or
NanoString arrays. DC5 in peripheral blood exhibit a spectrum of
CD123 and CD11c expression, with CD123hiCD11clo DC5
expressing a pDC-like gene signature and CD123loCD11chi
DC5 expressing a cDC2-like gene signature19. SS-BAL DC5
expressed more CD123, but a greater proportion of LPS-BAL
DC5 expressed CD11c (Fig. 4e). This was in keeping with a cDC2
over pDC bias in the inflamed airspace.
Alveolar macrophages orchestrate MP recruitment. We hypo-
thesized that resident AMs orchestrated the recruitment of leu-
kocytes into the alveolar airspace following LPS inhalation. LPS-
BAL AMs demonstrated high expression of chemokine genes
including CCL2-4 and CXCL10-11 (Fig. 5a, Supplementary
Dataset 1). Compared with SS-BAL AMs, LPS-BAL AMs
expressed 4 to 42-fold higher levels of these chemokine tran-
scripts. Only CXCL12 (stromal-cell derived factor) was not
expressed by AMs. Corresponding protein measurements of
secreted chemokines confirmed high expression of CCL2–4,
Fig. 2 CD14++CD16− monocyte-macrophage cells in LPS-BAL are recruited blood monocytes with transcriptional adaptations. a Expression of monocyte-
subset discriminating genes in CD14++CD16− cells from SS-BAL (blue square) and LPS-BAL (red square) compared with HC blood classical (filled green
square), intermediate (divided green square) and non-classical (open green square) monocytes. Gene expression was quantified by NanoString array. The
left-hand column contains genes with higher expression in classical than intermediate or non-classical monocytes. The right-hand column contains genes
with higher expression in intermediate and non-classical than classical monocytes. Bars represent mean ± SEM. b Principal component analysis of immune
gene expression (579-gene NanosString array) by BAL monocyte/macrophages and blood monocyte subsets. c Analysis of differentially expressed genes
(DEGs) in BAL CD14++CD16− cells and HC blood monocytes. Comparisons were made by unpaired t-test with p < 0.05 and >3-fold difference in mean
expression. Venn diagram shows DEGs in CD14++CD16− MPs from SS-BAL, LPS-BAL and HC blood. Circles represent DEGs between SS BAL and blood
(cyan; 101 genes, 22%) and between LPS-BAL and blood (yellow; 124 genes, 27%). The overlapping circles represents DEGs shared between comparisons
(49 genes, 11%). The top 10 upregulated genes (standard type) and top 5 downregulated genes (italic type) in BAL relative to blood are listed. Heatmap
shows DEGs common to both SS-BAL and LPS-BAL CD14++CD16- cells relative to HC blood classical monocytes. “Relative gene expression” refers to log2
transformed normalized gene expression count data. Genes with >10-fold difference in mean expression are shown. Genes discussed in text are colored
burgundy. d Heatmap showing DEGs between SS-BAL and LPS-BAL CD14++CD16− cells. Comparisons were made by unpaired t-test with p < 0.05. Genes
with >5-fold difference in expression are shown. Genes discussed in the text are colored burgundy
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CXCL10, and CXCL12 in LPS-BAL supernatant (Fig. 5b). mRNA
profiling of the cognate chemokine receptors revealed their
abundance on blood monocytes and DC2/DC3 (Fig. 5c), in
keeping with our findings of their recruitment into BAL following
LPS challenge.
Finally, we evaluated the dynamics of pro-inflammatory cytokine
secretion by resident AMs and recruited CD14++CD16−
monocyte–macrophages isolated from LPS-BAL. Both resident
LPS-BAL AMs and recruited LPS-BAL monocyte–macrophages
secreted high levels of pro-inflammatory cytokines upon re-
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stimulation with LPS in vitro, suggesting a coordinated partnership
between early resident AM response which is further amplified by
recruited CD14++CD16− monocyte–macrophages in mediating
early acute tissue inflammation (Fig. 5d).
Discussion
The human MP system is a complex repertoire of innate immune
cells distributed across distinct anatomical compartments that
serve heterogeneous functions in the inflammatory response.
Unraveling this complexity is necessary to understand tissue
immune surveillance, immunopathology and inform vaccine
design.
In keeping with previous reports15,31,32, we identified alveolar
airspace DC subsets (DC1, DC2/DC3, and pDC) corresponding
to those previously described in peripheral blood. We established
that BTLA distinguishes two CD1c+ DC subsets in BAL with
equivalent gene expression profiles to DC2/CD5+ DCs and DC3/
CD5lo DCs in blood19,33. Separate CD1c+ subsets have also been
described in skin and arise independently from haematopoietic
precursors, confirming that these are stable subsets and not
simply variations in activation state33. We showed that BTLA
expression is another reliable marker of DC1 in blood and lung
and verified the identity of sorted BTLAhi cells through their
expression of DC1 defining genes (e.g., XCR1, TLR3, and IRF8).
Two other studies14,18 did not identify DC1 in lung interstitial
tissue, which may be explained by the experimental design and
gating strategy used for analysis. We identified a distinct pDC
population in BAL, consistent with some reports15,17,34 but not
others18. The inconsistent finding of pDC in BAL does not arise
from their selective vulnerability to cryopreservation17. Although
Desch et al. did not find a CD123+CD303+pDC population in
healthy lung tissue, CD303+ cells were identified in tumor-
bearing lung14, possibly indicating that pDCs in lung are
restricted to the alveolar airspace and only present in parenchyma
during pathological situations.
By mapping alveolar airspace MP subsets relative to blood
populations, we were able to compare MP populations across
compartments upon LPS-delivery into the airway. In most pre-
vious studies, tissue inflammatory composition has been exam-
ined in isolation without reference to blood and origins have been
inferred35–37. Due to our referencing of blood it appeared logical
that CD14++CD16− MPs infiltrating BAL would be monocytes
recruited from blood with tissue adaptation, but the nature of
tissue adaptation required investigation. In both mouse and
human studies, monocytes recruited to tissues can acquire DC or
macrophage characteristics20,22,26. Monocytes have also been
described entering tissue with minimal adaptation38. The type of
MP characteristics adopted is highly relevant to the subsequent
immune response as macrophages and DCs differ in capacity for
migration, phagocytosis, ability to induce adaptive immune
responses and in the cytokine/chemokine secretion profile.
Through analysis of immune gene expression we established that
recruited alveolar CD14++CD16− cells in LPS-BAL and their
counterpart in SS-BAL were distinct from blood monocytes. They
expressed a broad array of genes important for mature macro-
phage function including phagocytic receptors, immunor-
egulatory proteins and cytokines. Despite the LPS activation
signature present in recruited cells, there was commonality in
the gene expression profiles of steady state and inflammatory
CD14++CD16− cells, emphasizing the importance and rapidity
of the impact of tissue microenvironment on shaping monocyte
fate following extravasation.
In addition to the expansion of monocyte–macrophages,
we identified several DC subsets expanded in the alveolar
airspace. Recruitment of DC from the blood to the gas exchan-
ging regions of the previously healthy human lung during
early inflammation has never been documented before. This
recruitment was observed for specific DC subsets, including
CD1c-expressing DC2/3 and Axl+Siglec6+ DC5 but not DC1 and
pDCs. Sequential analysis of peripheral blood DC2/3
following LPS inhalation detected significant depletion during
the period of accumulation in BAL. Analysis of surface
antigens with differential expression between blood and tissue
demonstrated that recruited DC had an antigen profile compar-
able with blood, consistent with recruitment of blood DCs and
providing evidence against translocation of DCs from the lung
interstitium. In the most comprehensive description of human
inflammatory DCs to date, CD1c-expressing DCs in chronic
inflammatory exudates were transcriptionally aligned to in vitro
monocyte-derived DCs26. This fits with numerous observations
in mouse that monocyte-derived cells accumulate in tissues
under inflammatory conditions and can adopt DC
characteristics3,5,20,23,25. In vivo data suggests it takes at least
24–48 h for monocytes to differentiate into DCs39 and in vitro,
generation of DCs from monocytes (human) or bone-marrow
derived cells (mouse) takes 5–7 days40,41. In view of our 8-h time-
course, the rapid accumulation of CD1c+ DCs into alveolar air-
space following LPS inhalation is most in keeping with recruit-
ment from blood and is consistent with previous observations of
CD1c+ DCs accumulating in bronchial (conducting airway)
mucosa within 4 h of allergen challenge35, though detailed ana-
lyses of the infiltrating population was not possible in this earlier
study. Transcriptome analysis further distinguished in vitro
monocyte-derived DCs from LPS-BAL DCs. Our data suggest
that in acute tissue inflammation, CD1c+ DCs, including a subset
with shared expression of monocyte genes, can be directly
recruited from blood and arise independently of monocyte-
Fig. 3 CD1c+ DCs in LPS-BAL are likely to be tissue-recruited blood CD1c+ DCs. a Expression of surface antigens by flow cytometry on DC2/3 from HC
blood (green), SS-BAL (blue) and LPS-BAL (red) relative to isotype control (gray). Antigens predicted to discriminate between blood and tissue CD1c+ DCs
were tested. Representative plots from more than three experiments are shown. b Dendrogram showing hierarchical clustering of monocyte/macrophage
and DC gene expression by indicated subsets isolated from HC blood and SS/LPS BAL. In vitro monocyte-derived DCs were also included. Clustering used
Pearson correlation metric. Monocyte/macrophage and DC identifying genes were taken from McGovern et al.28. The 25 genes available on the
NanoString Immunology v2 panel were used. c Proliferation of allogeneic peripheral blood T cells measured by CSFE dilution during 7-day co-culture with
or without MP subsets isolated from LPS BAL. Flow cytometry plots are gated on CD3+ T cells from a representative experiment. Summary graph shows
2–3 replicates per subset. Bars show mean ± SEM. Means were compared by one-way ANOVA with Dunnett’s multiple comparison test of DC2/3 against
other subsets. *p < 0.05. d Analysis of differentially expressed genes (DEGs) by DC2/3 from SS/LPS-BAL and HC blood. Comparisons were made by
unpaired t-test with p < 0.05 and >3-fold difference in mean expression. Venn diagram shows DEGs in DC2/3 from SS-BAL, LPS-BAL, and HC blood.
Circles represent DEGs between SS BAL and blood (cyan; 154 genes, 33%) and between LPS-BAL and blood (yellow; 124 genes, 39%). The overlapping
circles represents DEGs shared between comparisons (100 genes, 21%). The top 10 upregulated genes (standard type) and top 5 downregulated genes
(italic type) in BAL relative to blood are listed. Heatmap shows DEGs common to DC2/3 in both SS-BAL and LPS-BAL relative to HC blood. Genes
with >10-fold difference in mean expression are shown. Genes discussed in the text are colored burgundy. e Heatmap showing DEGs between DC2/3 from
SS-BAL and LPS-BAL. Genes with >10-fold difference in mean expression are shown. Genes discussed in the text are colored burgundy
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differentiation. This finding is likely to reflect the early time-point
we were able to study in our experimental model. Later char-
acterization of BAL following experimental inflammatory stimuli
and analysis of chronic disease states will reveal whether
monocyte-derived DCs arise subsequent to this initial inflam-
matory DC influx.
We propose that resident AMs operate to recruit DCs into the
alveolar airspace, in addition to their role in recruiting neu-
trophils and monocytes. Activation of AMs by LPS resulted in
rapid upregulation of chemokines involved in leukocyte migra-
tion and pro-inflammatory cytokine mediators, elucidating how
robust neutrophil recruitment and lung inflammation can be
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observed even after monocyte-depletion in a human LPS inha-
lation model42. The acute inflammatory cascade initiated by
resident AMs is further amplified by recruited CD14++CD16−
monocyte-macrophages.
There are a number of limitations to this study. LPS inhalation
provides the opportunity to study early time points in inflam-
mation but it is not an accurate representation of human disease.
Infective stimuli are rarely presented to the immune system as
single bolus and will frequently be accompanied by other
pathogen-associated molecular patterns. BAL permits effective
sampling of the alveolar space, but “leaves behind” alveolar epi-
thelial cells, adherent infiltrating cells, and those migrating
through the interstitium. These populations could make impor-
tant contributions to the regulation of the inflammatory response
but cannot be sampled without recourse to biopsies that are
unlikely to be ethical in healthy volunteers and may be subject to
sampling error. Furthermore, BAL itself is inflammatory to the
alveolar region, limiting the opportunity to study serial cell
migration in the same individual, or to assess “recovery” BAL
samples in this setting.
Our study has permitted detailed phenotypic, transcriptional,
and functional analyses of MPs present in the alveolar airspace of
healthy volunteers inhaling saline control or LPS to induce acute
local inflammation. In LPS-BAL, we observed perturbation of the
MP profile, noting significant influx of CD14++CD16−
monocyte–macrophages and selected DC subsets, likely regulated
by resident AMs. This finding adds to our understanding of the
potential role of blood DCs and the possibility of monocyte-
independent inflammatory DCs at early time points in acute
inflammation. Understanding the in vivo kinetics and dynamic
regulation of MP following local LPS stimulation extends biolo-
gical insights into the mechanisms of acute inflammation. Dis-
section of the functional consequences for the host will provide
the opportunity to understand both beneficial and detrimental
effects of such inflammation.
Methods
Ethical approval. The LPS inhalation study was approved by Newcastle & North
Tyneside 2 Research Ethics Committee of the NHS Health Research Authority
(REC reference number 12/NE/0196) under the full title “A lipopolysaccharide
(LPS) inhalation model to characterize divergent cellular innate immune responses
and presence of alveolar leak early in the course of acute lung inflammation”. The
study was conducted according to the principles expressed in the Helsinki
Declaration and informed consent was obtained from all participants.
Study population. The study was advertised to university undergraduates.
Potential recruits were invited to a screening interview to assess their suitability for
participation. Inclusion criteria were healthy adult volunteers aged 18 to 40 able to
give informed consent. Exclusion criteria were age <18 or >40 years; history of
chronic respiratory disease, diabetes, heart disease, renal disease or recurrent
infections; current respiratory tract infection; taking prescription medication
(except oral contraceptives); current smoking or history of smoking 20 cigarettes
per day for more than 2 years or any smoking in the past year; alcohol intake of
more than 21 units per week; pregnancy or lactation; abnormal examination
findings at screening (temperature >37.3 °C or oxygen saturation <95% breathing
room air); abnormal blood results at screening (hemoglobin concentration, total
white cell count or neutrophil count outside the gender-specific laboratory refer-
ence ranges; platelet count <100 × 109 l−1; serum sodium, potassium, creatinine or
alanine aminotransferase outside laboratory reference ranges; serum urea >10 mg
dl−1; serum bilirubin >30 μmol l−1); abnormal spirometry at screening (FEV1 or
FVC <80% predicted or FEV1:FVC ratio <70%). Eligible volunteers were given
verbal and written information about the study and at least 24 h to consider their
participation before signing a consent form. All primary research documents were
anonymised and participant details kept confidentially in accordance with Caldi-
cott guidelines. Data from 19 participants are presented (n= 10 LPS, n= 9 saline).
Study interventions. Volunteers were allocated to inhale 54 μl sterile 0.9% sodium
chloride with or without 60 μg LPS from E. coli 026:B6 (Sigma). Participants were
allocated sequentially to receive saline or LPS to give optimal control over
downstream experiments and they were not made aware of which intervention they
had received. Delivery was targeted at the lower airways using an automatic
inhalation-synchronized dosimeter nebulizer (Spira, Hameenlinna, Finland). The
test solution was released following inhalation of 50 ml air to ensure that laminar
flow was established. Participants performed a 5 s breath hold at vital capacity to
promote deposition of LPS in the lower respiratory tract.
Participants were asked about symptoms (flu-like symptoms, sore throat,
cough, wheeze, chest pain, sputum production, nasal secretions, or any other
symptom) immediately after inhalation and at 6 h. Body temperature was
measured hourly until 6 h. Venous blood samples were obtained at 0, 2, 4, 6, and
24 h after inhalation. We used blood leukocyte counts as the indicator of LPS effect.
Flexible fiber-optic bronchoscopy was performed 8 h after inhalation.
Intravenous sedation with midazolam was available but all participants elected for a
non-sedated procedure. Participants received topical administration of 1%
lignocaine spray to the mouth and pharynx. Bronchial wash of the upper airways
was performed with 20 ml warmed 0.9% sodium chloride and discarded. BAL of
the right middle lobe was performed with 150 ml warmed 0.9% sodium chloride
and retrieved by gentle suction.
Participant safety. History, bedside observations, cardio-respiratory examination,
and spirometry were performed immediately before LPS or saline inhalation.
Bedside observations were repeated hourly and spirometry repeated at 6 h after
inhalation. If FEV1 fell by 10% from baseline, bronchoscopy was canceled. Prior to
bronchoscopy, participants were fasted for 4 h. There was constant monitoring of
oxygen saturations and electrocardiogram during bronchoscopy. Patients were
observed for 30–60 min after bronchoscopy and allowed to leave if bedside
observations and cardio-respiratory examinations were normal. Written and verbal
advice was given to avoid eating and drinking within two hours of local anesthetic
administered to the mouth and pharynx. Participants were informed that LPS
inhalation and bronchoscopy may result in temperature, mild headache, shivering,
dry cough, and upper airway discomfort.
Cell isolation. Blood was collected into EDTA. PBMC were isolated by density
centrifugation using Lymphoprep (Stemcell technologies) according to manu-
facturers instructions. BAL samples were kept at room temperature for 60–90 min
before processing at 4 °C. BAL fluid was passed through a 100 µ filter (Falcon).
Following centrifugation, cell-free supernatant was stored at −80 °C and cells were
prepared for immediate analytical flow cytometry and cell sorting.
Fig. 4 The pool of recruited LPS-BAL CD1c+ DCs contains DC2 and DC3, which are functionally altered on entry to the inflamed airspace. a Volcano plot
shows DEGs between BTLA+ and BTLA− CD1c+ DCs from HC blood. DEGs were calculated by unpaired t-test with p-value adjustment using Benjamini-
Yekutieli method. Genes with p < 0.05 are displayed as text. Accompanying scatterplots verifiy that that blood BTLA+ and BTLA– CD1c+ DCs exhibit the
expected gene expression profile of DC2 and DC3 respectively. Plots show expression from n= 3 samples with bars showing mean ± SEM. b Comparison
of BTLA+:BTLA− ratio in CD1c+ DCs from HC blood, SS-BAL and LPS-BAL by flow cytometry. The gating strategy represented in Fig. 1b was used to define
CD1c+ cells. Flow cytometry plots show percentage of BTLA+ and BTLA− CD1c+ cells in representative examples of blood, SS-BAL and LPS-BAL.
Accompanying bar graph summarizes flow cytometry data from n= 4–9 replicates. Statistical comparison by one-way ANOVA with Dunnett’s
multiple comparisons tests. ns p > 0.05, **p < 0.01. c Heatmap showing expression of the 29 genes with differential expression between blood DC2 and
DC3 (p < 0.05 and fold difference >2) in DC2 and DC3 sorted from LPS-BAL and HC blood. Samples were clustered using Euclidian distance metric. d Flow
cytometry read-out of a T cell cytokine production assay following 10-day co-culture of allogeneic peripheral blood CD4+ T cells with macrophages
and DCs isolated from LPS-BAL. Accompanying bar graphs summarize flow cytometry data showing mean ± SEM IFN-γ and IL-17 production following
co-culture of SS-BAL (blue bars) or LPS-BAL (red bars) macrophages and DCs (each n= 2). Two-way ANOVA of IFN-γ production gives ***p < 0.001 for
SS-BAL vs. LPS-BAL and ns p= 0.07 for MP type. Two-way ANOVA of IL-17 production gives ns p= 0.06 for SS-BAL vs. LPS-BAL and ns p= 0.67 for MP
type. e Flow cytometry plots show representative examples of CD123 and CD11c expression by Axl+Siglec6+ DC5 in SS-BAL and LPS-BAL. The gating
strategy represented in Fig. 1b was used to define DC5. Gates demarcate CD11c-expressing cells. Accompanying scatterplot summarizes flow cytometry
data, showing proportions of DC5 expressing CD11c in SS-BAL (blue circles) and LPS-BAL (red squares). **p < 0.01 by unpaired t-test
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Flow cytometry and sorting. Cell pellets were washed in PBS (Sigma) supple-
mented with 2% fetal calf serum (Sera lab) and 2 mM EDTA (Invitrogen). The
following antibodies were applied for 20 min at 4 °C (clone; supplier; catalog
number; final concentration): anti-CD45-V500 (HI30; BD; 560777; 1:25), anti-
CD3-FITC (SK7; BD; 345763; 1:25), anti-CD19-FITC (AG7; BD; 347543; 1:25),
anti-CD20-FITC (L27; BD; 345792; 1:25), anti-CD56−FITC (NCAM16; BD;
345811; 1:25), anti-HLA-DR-BV786 (G46−6; BD; 307642; 1:25); anti-CD14−
BV650 (M5E2; Biolegend; 301835: 1:40), anti-CD16-PE/Dazzle-594 (3G8; Biole-
gend; 302054; 1:33), anti-CD11c-APCCy7 (Bu15; Biolegend; 337218; 1:33), anti-
CD123-PERCPCy5.5 (7G3; BD; 558714; 1:25), anti-CD1c-PECy7 (L161; Biolegend;
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331506; 1:40), anti-CD11b-APC (ICRF44; Biolegend; 301309; 1:25), anti-BTLA-PE
(J168–540; BD; 558485; 1:100), anti-Axl-APC (108724; R&D Systems; FAB154A:
1:33) and anti-Siglec-6-A700 (767329; R&D Systems; FAB2859N; 1:33). CD1c+ DC
phenotyping experiments additionally used anti-CD1a-AF700 (HI149; Biolegend;
300120; 1:50), anti-CD206-PE (19.2; BD; 555954, 1:25), anti-FcER1-PE (CRA1;
eBioscience; 12–5899–42; 1:25) and anti-CD86-PE (FUN-1; BD; 555658; 1:25).
Dead cells were excluded with DAPI (Partec). Analytical flow cytometry was
performed on a BD Fortessa X20 or BD FACSCanto II and cell sorting with a BD
FACS Fusion running FACSDiva version 7. Consistent instrument performance
was ensured by running Cytometer Setup and Tracking Beads (BD). PBMC were
periodically run through the analysis template as a biological control to ensure
gates were capturing the expected populations. Doublets were excluded with a SSC-
H vs. SSC-A plot. FlowJo version 9.6.7 was used for analysis. Sorting strategies are
given in Supplementary Fig. 3.
Peripheral blood MP quantitation. Quantitation of neutrophils and total
monocytes was by complete blood count (CBC) in a UKAS accredited clinical
laboratory using the Sysmex XE-2100. For MP subsets not quantitated in the CBC,
1 ml whole blood was lysed using an in-house ammonium chloride lysis buffer and
transferred to a Trucount tube (BD). Antibodies were applied as above and flow
cytometry performed following a final red cell lysis step. Data were acquired on a
BD Fortessa and cell concentrations calculated with reference to bead counts.
Chemokine/cytokine analysis. Chemokines and cytokines in BAL fluid super-
natant were quantified using multiplexed ELISA (ProcartaPlexTM 34−plex,
EBioscience). Captured analytes were detected on a Qiagen Liquichip 200 running
Luminex 100 integrated system software version 2.3. Procartaplex Analyst version
1.0 was used to define standard curves and determine analyte concentrations.
Gene expression analysis. Lysates from 1–2 × 104 cells per sorted population
were prepared using 5μl buffer RLT (Qiagen) with 1% beta-mercaptoethanol
(Sigma). Transcripts from 579 immunology genes were detected using a Nano-
String Immunology v2 panel according to the manufacturers instructions.
Experiments using blood and BAL DC2/3 included an additional 30-gene add-on
to the Immunology v2 panel, designed to detect DC and monocyte/macrophage
genes, including ASIP, DBN1, MERTK, C19orf59, F13A1, NDRG2, CCL17, FGD6,
PACSIN1, CD1C, FLT3, PPM1N, CD207, GCSAM, PRAM1, CLEC10A, GGT5,
S100A12, CLEC9A, Ki67, SIRPA, CLNK, LPAR2, TMEM14A, COBLL1, LYVE1,
UPK3A, CXCL5, MAFF, ZBTB46. Panels included 15 housekeeping genes. Data
normalization was performed in nSolver version 3, including a background sub-
traction step, positive control normalization using synthetic spike-in controls and
content normalization using a combination of 15 housekeeping genes.
T cell proliferation assay. T cells were isolated by negative selection from healthy
control peripheral blood collected into EDTA using RosetteSep Human T Cell
Enrichment Cocktail and Lymphoprep (Stemcell technologies). Aliquots were
cryopreserved at −80 °C. Thawed T cells were labeled with 1 μM CSFE (Invitrogen)
prior to co-culture. MP populations were sorted from BAL and co-cultured with
T cells at a 1:25 ratio in 96 well v-bottom plates containing RPMI 1640 (Lonza)
with 100 Uml−1 penicillin, 10 μg ml−1 streptomycin, 2mM L-glutamine (all Invi-
trogen) and 10% heat-inactivated fetal calf serum (Sera Lab). Cultures were
maintained for 7 days at 37 °C and 5% CO2. Outputs were prepared for flow
cytometry as described above using anti-CD3-V500 (UCHT1; BD; 561416; 1:50),
anti-CD4-PE (RTPA-T4; BD; 555347; 1:50), anti-CD8-APCCy7 (SK1; BD; 557834;
1:50) and analzyed on a FACS Canto II running FACSDIVA version 7. Three
experiments were performed on populations sorted from LPS BAL.
T cell cytokine production assay. CD4 T cells were isolated by negative selection
from healthy control peripheral blood collected into EDTA using RosetteSep
Human CD4 T cell enrichment cocktail. Aliquots were cryopreserved at −80 °C.
MP populations were sorted from SS-BAL or LPS-BAL and co-cultured with T cells
at a 33:1 ratio in 96-well round-bottom plates containing RF10. On day 6, medium
was replenished with RPMI 1640 with supplements as above and 10 U ml−1
human recombinant IL-2 (Immunotools). On day 10, cells were stimulated with
10 ng ml−1 phorbol 12-myristate 13-acetate (Sigma) and 1 μg ml−1 ionomycin
(Sigma) for 4 h, with 10 with brefeldin A (Sigma) added after the first hour. Dead
cells were stained with a Zombie Aqua (Biolegend) prior to fixation and per-
meabilization (BD) according to manufacturers instructions. Cells were prepared
for flow cytometry as above using anti-IFN-γ-PE/Dazzle-594 (4s.B3; Biolegend;
505845; 1:100), anti-IL17-AF647 (BL168; Biolegend; 512309; 1:100) and anti-IL4-
PECy7 (MP4–25D2; Biolegend; 500823; 1:100) and analyzed on a Fortessa X20
(BD) running FACSDIVA version 7.
Ex-vivo macrophage stimulation. Alveolar macrophages and CD14++CD16−
monocyte/macrophages were sorted from LPS BAL (n= 4 each). 1 × 105 sorted
cells were cultured in 96-well round bottom plates in 100 μl RPMI 1640 with
supplements (as above) containing 100 ng ml−1 LPS from E. coli (Sigma). After
10 h, supernatants were harvested and stored at −80 °C. Supernatants were batch-
analysed by cytometric bead array (BD) to detect IL-10, IL-1β, TNF, IL-6, and IL-8.
Bead populations were resolved on a FACS Canto II running FACSDIVA Version
7 and analyzed using FCAP Array software version 3.
Generation of monocyte-derived dendritic cells (moDC). Classical monocytes
were isolated from healthy control peripheral blood by density centrifugation and
FACS sorting. 5 × 105 monocytes were cultured in 500 μl RPMI 1640 with sup-
plements (as above) in 24-well plates for 5 days at 37 °C and 5% CO2. Medium
contained 50 ng ml−1 GM-CSF (R&D) and 50 ng ml−1 IL-4 (Immunotools).
Medium and cytokines were refreshed on day 3. Cells were harvested and FACS-
sorted on day 5, to exclude undifferentiated CD14+ monocytes and include only
CD1c+ moDC.
Statistical analysis. Statistical analyses stated in the text were performed using
GraphPad Prism version 7.0. Gene expression analyses were performed in Multi-
Experiment Viewer version 10.2 and nSolver v4 advanced analysis module.
Data availability
NanoString gene expression data have been deposited in Gene Expression Omnibus
(GEO) with the accession code GSE126923. Other data that support the findings of this
study are available from the corresponding author upon reasonable request.
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